Market revenue in 2023 | USD 317.9 million |
Market revenue in 2030 | USD 542.6 million |
Growth rate | 7.9% (CAGR from 2023 to 2030) |
Largest segment | Repetitive transcranial magnetic stimulation (rtms) |
Fastest growing segment | Deep Transcranial Magnetic Stimulation (dTMS) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Deep Transcranial Magnetic Stimulation (dTMS), Repetitive Transcranial Magnetic Stimulation (rTMS) |
Key market players worldwide | BrainsWay Ltd ADR, Nexstim Oyj Registered Shs Reg S, The Magstim Company, Salience, MagVenture, eNeura Therapeutics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to transcranial magnetic stimulation system market will help companies and investors design strategic landscapes.
Repetitive transcranial magnetic stimulation (rtms) was the largest segment with a revenue share of 38.85% in 2023. Horizon Databook has segmented the U.S. transcranial magnetic stimulation system market based on deep transcranial magnetic stimulation (dtms), repetitive transcranial magnetic stimulation (rtms) covering the revenue growth of each sub-segment from 2018 to 2030.
BrainsWay Ltd.; Neuronetics, Inc.; TMS Neuro Solutions; MagVenture, Inc.; eNeura, Inc. are some of the key players in the transcranial magnetic stimulation system market headquartered in the U.S. One of the top TMS systems on the market is NeuroStar, by Neuronetics.
The favorable reimbursement scenario provides access to healthcare services related to brain treatment to a large portion of the population. Subsequently, it creates a demand for cost-effective and efficient TMS system.
This also increases the need for cost-effective TMS system and the integration of digital health with other care delivery systems. Hence, many companies are seeking U.S. FDA approval to launch their products in the U.S. market.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. transcranial magnetic stimulation system market , including forecasts for subscribers. This country databook contains high-level insights into U.S. transcranial magnetic stimulation system market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account